Compare CHE & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CHE | BIRK |
|---|---|---|
| Founded | 1970 | 1774 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 6.1B |
| IPO Year | 1994 | 2023 |
| Metric | CHE | BIRK |
|---|---|---|
| Price | $390.01 | $37.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 14 |
| Target Price | ★ $498.00 | $62.69 |
| AVG Volume (30 Days) | 236.8K | ★ 2.0M |
| Earning Date | 04-23-2026 | 05-14-2026 |
| Dividend Yield | ★ 0.62% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 18.34 | N/A |
| Revenue | ★ $2,529,978,000.00 | N/A |
| Revenue This Year | $6.60 | $13.76 |
| Revenue Next Year | $6.15 | $14.29 |
| P/E Ratio | $21.19 | ★ $17.48 |
| Revenue Growth | ★ 4.06 | N/A |
| 52 Week Low | $365.21 | $33.06 |
| 52 Week High | $604.91 | $57.39 |
| Indicator | CHE | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 50.35 | 53.69 |
| Support Level | $385.00 | $33.06 |
| Resistance Level | $458.07 | $42.19 |
| Average True Range (ATR) | 8.88 | 1.59 |
| MACD | 3.94 | 0.24 |
| Stochastic Oscillator | 98.35 | 92.43 |
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.